Search

Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.

A diverse range of malaria treatments will make all the difference in the prevention of resistance.

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

In the 20th century, physics and chemistry reshaped the world. Here’s why biology will be the game-changer in the 21st century.

What are the challenges and best practices in quality control for difficult-to-inspect products?

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

Looking to pivot your business model to a CDMO service offering? Here’s what to keep in mind.

How can we maximize the potential and production of potentially life-saving therapies?

Find out how a random act of kindness set Antoinette Gawin on the path to becoming a VP in her twenties.